Browse diseases

…se I trial data demonstrates clinical activity in patients with solid tumors, with a number of durable responses. This data supports the pot…

…have shown promising efficacy and safety in clinical trials for gastric cancer, but have struggled to achieve complete, durable responses due …

…s mechanism and activity in combination with approved agents in gastric cancer.…

…e shown for (C) CRC molecular subtype (CIN, GS and MSI) and (D) CRC disease stage. CALCRL gene expression z-scores are displayed fo…

…ome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study’ by Cai et a…

…ritical to avoid exacerbating existing inequities. For example, prostate cancer incidence is higher in black patients.55 Further, incidence, pa…

…2% for colorectal cancer, 20.6% for breast cancer, and 6.1% for cervical cancer. Overscreening among younger age groups primarily occurred in w…

… assessment of clinical features and gastric neoplastic risk in autoimmune gastritis (AIG).1 Among 1240 patients with AIG across eight centres, the …

…ts a promising strategy to potentiate PD-1 blockade efficacy in gastric cancer peritoneal metastasis.…

…imising biopsy strategies and improving risk stratification for gastric cancer, including the RE.GA.IN. consensus,1 long-term natural history …

…er disease and chronic gastritis and also has associations with gastric cancer.2 ESPGHAN/NASPGHAN guidelines recommend targeted testing, eradi…

…sinogen testing has been widely used as a non-invasive tool for gastric cancer risk stratification; however, its diagnostic performance varies…